CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
Boston Children's Hospital · Harvard University · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
650
total citations
- FWCI
- 27.48
- Percentile
- 100%
- References
- 80
Citations per year
Authors
16- ECEdmond ChipumuroCorresponding
Boston Children's Hospital, Harvard University, Dana-Farber Cancer Institute
- EMEugenio Marco
Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center
- CLCamilla L. Christensen
Dana-Farber Cancer Institute
- NKNicholas Kwiatkowski
Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology
- TZTinghu Zhang
Harvard University, Dana-Farber Cancer Institute
Topics & keywords
Topics
Keywords
- Biology
- Enhancer
- Transcription (linguistics)
- Cancer research
- Transcription factor
- Genetics
- Cell biology
- Gene
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.